Cresco Labs (CRLBF) Income towards Parent Company (2020 - 2026)

Cresco Labs (CRLBF) posted Income towards Parent Company of -$13.3 million for Q1 2026, up 84.45% on a QoQ basis from -$85.3 million in Q4 2025, and up 8.04% year-over-year from -$12.3 million in Q1 2025.

Cresco Labs (CRLBF) Income towards Parent Company (2020 - 2026) Analysis & Trends

Cresco Labs' Income towards Parent Company history runs 7 years deep, the most recent figure standing at -$13.3 million for Q1 2026.

  • Quarterly Income towards Parent Company rose 8.04% year-over-year to -$13.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$132.2 million (down 79.26% YoY) and the FY2025 annual result came in at -$140.0 million, down 131.52% from the prior year.
  • Income towards Parent Company was -$13.3 million for Q1 2026 at Cresco Labs, up from -$85.3 million in the prior quarter.
  • Across five years, Income towards Parent Company topped out at $5.7 million in Q4 2024 and bottomed at -$161.3 million in Q4 2022.
  • A 5-year average of -$35.2 million and a median of -$16.3 million in 2025 frame the typical range for Income towards Parent Company.
  • Annual changes were most pronounced in 2024 — Income towards Parent Company jumped 115.22% — and 2025, when it sank 1604.87%.
  • Cresco Labs' Income towards Parent Company stood at -$161.3 million in 2022, then surged by 101.63% to $2.6 million in 2023, then surged by 115.22% to $5.7 million in 2024, then sank by 1604.87% to -$85.3 million in 2025, then soared by 84.45% to -$13.3 million in 2026.
  • Business Quant data shows CRLBF's Income towards Parent Company at -$13.3 million in Q1 2026, -$85.3 million in Q4 2025, and -$17.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 89.28 Bn 87.42 Bn -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn
10 Cresco Labs 245.85 Mn 182.28 Mn 75.45 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -13.27 Mn
Dec 31, 2025 -85.34 Mn
Sep 30, 2025 -17.29 Mn
Jun 30, 2025 -16.33 Mn
Mar 31, 2025 -14.43 Mn
Dec 31, 2024 5.67 Mn
Sep 30, 2024 -10.54 Mn
Jun 30, 2024 -54.46 Mn
Mar 31, 2024 -5.51 Mn
Dec 31, 2023 2.64 Mn
Sep 30, 2023 -115.57 Mn
Jun 30, 2023 -36.53 Mn
Mar 31, 2023 -26.05 Mn
Dec 31, 2022 -161.34 Mn
Sep 30, 2022 -9.79 Mn
Jun 30, 2022 -13.54 Mn
Mar 31, 2022 -27.38 Mn
Dec 31, 2021 -624.46 Mn
Sep 30, 2021 -270.65 Mn
Jun 30, 2021 -4.83 Mn